Our data uncovered that KLF13 directly bound to the SH2B1 promoter to restrain its transcription and expression, thereby inhibiting glycolysis to delay progression of NSCLC in vitro and in vivo. This evidence concerns the gene KLF13 and non-small cell lung carcinoma.